Depletion of YAP yielded observations similar to those after depletion of both ERK1 and ERK2, suggesting that ERK1/2 inhibition restrains the migratory ability of the NSCLC tumor cells possibly through YAP down-regulation. The gene discussed is MAPK3; the disease is neoplasm.